...Anna Meta Dyrvig Kristensen; Manan Pareek; Kristian Hay Kragholm; Thomas Steen Gyldenstierne Sehested; Michael Hecht Olsen; Eva Bossano Prescott Background: Unstable angina (UA) is a component of acute coronary syndrome that is only occasionally included in primary composite endpoints in clinical...

... of antithrombotic strategy in patients with acute coronary syndromes and AF treated with coronary stenting enrolled in the prospective, observational, nationwide MATADOR-PCI study. Results: Among the 588 patients discharged alive, a TAT was prescribed in 381 (64.8%) and DAT in 52 (8.8%) patients. According...

...Gudny Stella Gudnadottir; Thorarinn Gudnason; Katarina Wilhelmson; Annica Ravn-Fischer Aims: This study aimed to examine the multimorbidity as well as the 30-day and 1-year readmission rates in a large, unselected cohort of elderly patients with acute coronary syndrome (ACS). Methods and Results...

.... Electrocardiogram Acute coronary syndromes Acute myocardial infarction Syncope • Wellens syndrome is a known variant of acute coronary syndromes. • Myocardial ischemia can precipitate arrhythmias or an exaggerated neurally mediated response and lead to syncope. • We identified an atypical...

... of the most common manifestations of acute coronary syndromes (ACS). We evaluated the prognostic role of cardiac troponin I (cTnI) at presentation and peak cardiac troponin I in patients with NSTEMI. Methods: We consecutively enrolled 215 subjects presenting with NSTEMI. Subjects were followed up for 1 year...

...B.E. Stähli; C. Gebhard; K. Yonekawa; C.E. Gebhard; L.A. Altwegg; A. von Eckardstein; M. Hersberger; I. Novopashenny; R. Wolters; M.B. Wischnewsky; T.F. Lüscher; W. Maier Objectives: Gender differences in patients presenting with suspected acute coronary syndromes (ACS) have not yet been fully...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Acute coronary syndromes Angiography Coronary flow Clopidogrel PLATO trial Platelet activity Substudy Ticagrelor Major indication-seeking phase 3 clinical trials usually include...

...Asfandyar K. Niazi; James J. DiNicolantonio; Carl J. Lavie; James H. O'Keefe; Pascal Meier; Sripal Bangalore Dual antiplatelet therapy (DAPT) with aspirin and a P2Y 12 receptor antagonist is the standard of care in acute coronary syndromes. Additionally, novel P2Y 12 receptor antagonists...

... to in the content or advertisements. Acute coronary syndromes Clopidogrel Dosing Mortality Statins Ticagrelor The PLATO trial was a phase-3, randomized, double-blind, parallel-group, multinational, clinical study comparing the efficacy of ticagrelor versus clopidogrel. Patients (n = 18,624...

... of vital records in the national death registries. Two recently completed acute coronary syndrome (ACS) trials, TRACER and ATLAS ACS 2 (Thrombin Receptor Antagonist for Clinical Event Reduction in ACS and Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with ACS...

...) score at admission in patients with non-ST elevation acute coronary syndromes (ACS). Methods: A total of 225 consecutive patients with non-ST elevation ACS were studied. Hemoglobin was measured at admission, and its prognostic value was evaluated in relation to cardiovascular events during...

... risk factors in patients with acute coronary syndromes (ACS). Methods: Between July 2008 and September 2009, 497 consecutive patients with ACS who were admitted to the West China Hospital of Sichuan University were enrolled and underwent CYP2C19*2 determination. The clinical outcomes were the composite...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Acute coronary syndromes Coronary angiography Acute myocardial infarction Thrombosis Antiplatelet agents Lupus Fig. 1 Initial electrocardiogram showing acute pericarditis...

...W. Rafflenbeul Early stages of the atherosclerotic plaque are considered to be responsible for about 2/3 of all acute coronary syndromes. Therefore, suppression of this initial stage of plaque formation constitutes a major target to reduce the incidence of the disease itself as well as its...

...Douglas D. Yun; Joseph S. Alpert Acute coronary syndromes are defined as unstable angina, non-Q-wave myocardial infarction, and Q-wave myocardial infarction. These entities remain among the commonest life-threatening illnesses in industrialized nations. Prompt recognition of a patient with an acute...

..., instructions or products referred to in the content or advertisements. Acute coronary syndromes Acute myocardial infarction Cardiac magnetic resonance Microvascular obstruction In the course of acute ST-elevated myocardial infarction (STEMI) treated by early reperfusion therapy, microvascular...

...Jette Mortensen; Sofie S. Thygesen; Søren P. Johnsen; Peter M. Vinther; Steen D. Kristensen; Jens Refsgaard Objective: Randomized clinical trials have reported low risks of bleeding in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients receiving triple antithrombotic treatment...

...F. Cuculi; D. Radovanovic; F.R. Eberli; J.C. Stauffer; O. Bertel; P. Erne Objectives: The role of statin use in the treatment of acute coronary syndromes (ACS) is not clear. The aim of our study was to evaluate the role of statins in ACS. Methods: Using data from the Acute Myocardial Infarction...

...Avital Porter; Zaza Iakobishvili; Rita Dictiar; Solomon Behar; Hanoch Hod; Shmuel Gottlieb; Haim Hammerman; Doron Zahger; David Hasdai Background/Aims: Physicians’ perception of antecedent physical/cognitive status may account for the suboptimal implementation of acute coronary syndrome (ACS...

...R. Nieuwlaat; M. Lenzen; H.J.G.M. Crijns; M.H. Prins; W.J. Scholte op Reimer; A. Battler; D. Hasdai; N. Danchin; A.K. Gitt; M.L. Simoons; E. Boersma Background/Aims: A large proportion of patients with a ST-elevation acute coronary syndrome do not receive reperfusion therapy. In order to contribute...